Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Shares Repurchased (2017 - 2025)

Avanos Medical (AVNS) has disclosed Shares Repurchased for 9 consecutive years, with $300000.0 as the latest value for Q4 2025.

  • Quarterly Shares Repurchased rose 200.0% to $300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, down 74.22% year-over-year, with the annual reading at $3.3 million for FY2025, 74.22% down from the prior year.
  • Shares Repurchased hit $300000.0 in Q4 2025 for Avanos Medical, down from $800000.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $19.4 million in Q1 2022 to a low of $100000.0 in Q3 2021.
  • Historically, Shares Repurchased has averaged $5.1 million across 5 years, with a median of $2.4 million in 2023.
  • Biggest five-year swings in Shares Repurchased: soared 10900.0% in 2022 and later plummeted 98.91% in 2024.
  • Year by year, Shares Repurchased stood at $10.9 million in 2021, then tumbled by 96.33% to $400000.0 in 2022, then soared by 1450.0% to $6.2 million in 2023, then tumbled by 98.39% to $100000.0 in 2024, then surged by 200.0% to $300000.0 in 2025.
  • Business Quant data shows Shares Repurchased for AVNS at $300000.0 in Q4 2025, $800000.0 in Q2 2025, and $2.2 million in Q1 2025.